Insulet Corporation (PODD)
$159.56+3.73%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Tubeless insulin leader growing 30% yearly; the vast Type 2 diabetes market is barely tapped.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes …
- Sector:
- Healthcare
- Industry:
- Medical Devices
- Market Cap:
- $10.4B
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Insulet Corporation and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free